RxDoctor Payments Data

Daniel Steier

Family Medicine · Omaha, NENPI 1265582266

Payments from drug & device makers

$1,413in general payments, 2019–2025

Across 97 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$192
  • Amarin Pharma, Inc.$168
  • Boston Scientific$164
  • AstraZeneca$110
  • Amgen$109
  • Sanofi-aventis U.S. LLC$95
  • plus $574 from 18 others

What the payments were for

  • Food & beverage$1,407100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,413 in reported general payments places this provider in the 65th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Other family medicine in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →